SCHEMBL863536

SCHEMBL863536

[CH2]C1COCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2304373 1.00
SCHEMBL2306505 1.00
SCHEMBL1361148 0.71
SCHEMBL19581786 0.69
SCHEMBL22529636 0.68
SCHEMBL26278 0.68
SCHEMBL573582 0.67 CHRM2 (0.37)
SCHEMBL29742575 0.67 CHRM2 (0.37)
SCHEMBL482114 0.67
SCHEMBL11269 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 560 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024127350-A1 2,6,9-TRISUBSTITUTED PURINES ASTRAZENECA AB (SE) 2024-06-20 WO claimed
CN-118201916-A Piperazinylsulfonylaryl compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-06-14 CN claimed
CN-115135656-B Furanoindazole derivatives 拜耳公司 2024-06-14 CN claimed
US-11981686-B2 Urea compound having substituent DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-05-14 US claimed
CN-112654608-B Fused ring compound having urea structure 桑福德伯纳姆普利斯医学发现研究所 2024-05-07 CN claimed
WO-2024083705-A1 FUROINDAZOLE DERIVATIVES FOR THE TREATMENT OF PAIN BAYER AKTIENGESELLSCHAFT (DE) 2024-04-25 WO claimed
CN-113423711-B Thieno [3,2-B ] pyridine derivatives as UDP glycosyltransferase inhibitors and methods of use thereof 建新公司 2024-03-15 CN claimed
US-11918568-B2 Fused ring compound having urea structure Sanford Burnham Prebys Medical Discovery Institute (US) 2024-03-05 US claimed
US-20230132298-A1 OXABOROLE ESTERS AND USES THEREOF ANACOR PHARMACEUTICALS, LLC 2023-04-27 US claimed
US-20230112499-A1 FUROINDAZOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US claimed
EP-0289913-A2 Parasiticidal agent based on substituted aminomethyl heterocycles BAYER AG (DE) 1988-11-09 EP claimed
EP-0278311-A1 2-Aminomethyl tetrahydrofuranes BAYER AG (DE) 1988-08-17 EP claimed
EP-0088046-B1 LIPIDS IN THE AQUEOUS PHASE CIBA-GEIGY AG (CH) 1987-12-09 EP claimed
US-4619794-A Spontaneous preparation of small unilamellar liposomes CIBA-GEIGY CORPORATION (US) 1986-10-28 US claimed
EP-0031796-B1 4-HETEROCYCLYL-4'-VINYL-STILBENES CIBA-GEIGY AG (CH) 1985-01-23 EP claimed
US-4366189-A WHITENERS CIBA-GEIGY CORPORATION (US) 1982-12-28 US claimed
EP-0031796-A2 4-Heterocyclyl-4'-vinyl-stilbenes CIBA-GEIGY AG (CH) 1981-07-08 EP claimed
US-4173630-A N2 Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1979-11-06 US claimed
US-4125604-A PEPTIDES, ANTITHROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1978-11-14 US claimed
US-4101653-A ANTITHROMBOSIS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1978-07-18 US claimed